Iridian Asset Management Q3 2026: Significant Stock Purchases and Sales Observed

Investor Profile: Iridian Asset Management

Iridian Asset Management LLC/CT, a significant player in the investment landscape, reported its portfolio holdings as of September 30, 2026, in a regulatory filing. The fund managed a total portfolio value of $274.8 million during this period, reflecting its substantial investment presence. For more information on Iridian Asset Management's activities, you can visit their profile on InsiderSet.

Observed Purchases: New Positions and Increased Holdings

This quarter, Iridian Asset Management LLC/CT demonstrated active buying behavior, establishing new positions and increasing stakes in several companies. The filing indicates that the fund has taken significant positions in Hilton Grand Vacations Inc. (HGV), acquiring shares that increased its stake substantially. Similarly, Nektar Therapeutics (NKTR) saw a notable increase in holdings, with the fund adding shares representing a significant percentage jump in the position.

Other noteworthy purchases include Rentokil Initial PLC (RTO), where Iridian increased its stake by 54.15%. The fund also boosted its position in Bellarings Brands Inc. (BRBR) by 56.01%, indicating strong confidence in this Consumer Defensive company. Furthermore, the investment in Xylem Inc. (XYL) was newly initiated by the fund, suggesting it identified potential value in this Industrials stock.

These buying activities span different sectors. For instance, Clarivate PLC (CLVT) in Technology, Innoviva Inc. (INVA) in Healthcare, and Katapult Holdings Inc. (KPLT) in Technology show diversification in Iridian's purchasing strategy. The fund also added to its holdings in Bill Holdings Inc. (BILL) and Gen Digital Inc. (GEN), both in the Technology sector.

Observed Sales: Decreased Holdings and Position Reductions

Conversely, Iridian Asset Management LLC/CT also showed significant selling activity during the quarter. The fund reduced its holdings in several major positions. Notably, the stake in ACV Auctions Inc. (ACVA) decreased by 32.89%, a substantial reduction. Similarly, the investment in Precigen Inc. (PGEN) saw a decline of 23.99%.

Other sales include reductions in Herbalife Ltd. (HLF) by 0.91%, Lithia Meters Inc. (LAD) by 26.72%, and Travel Plus Leisure Co. (TNL) by 3.95%. The fund also partially exited its positions in Axsome Therapeutics Inc. (AXSM) and Element Solutions Inc. (ESI).

The sales primarily occurred within the Consumer Cyclical sector, which saw reductions in holdings of ACV Auctions Inc., Herbalife Ltd., Hilton Grand Vacations Inc., Lithia Meters Inc., and Travel Plus Leisure Co.. There was also a sale in the Healthcare sector, specifically in Axsome Therapeutics Inc..

Overall Portfolio Changes and Insights

The observed changes indicate a dynamic portfolio for Iridian Asset Management LLC/CT. The fund appears to be strategically reallocating capital, favoring certain growth areas while reducing exposure in others. The significant buying in Hilton Grand Vacations Inc. and Nektar Therapeutics suggests an interest in leisure/property and healthcare/pharmaceutical plays, respectively.

While the fund engaged in substantial selling, notably in ACV Auctions Inc. and Precigen Inc., there were no disclosed large-scale selling activities that would significantly alter the overall portfolio structure. The total number of holdings remained high at 40, and the fund maintained a heavy concentration in Consumer Cyclical stocks, which collectively accounted for 46.38% of the top five holdings by weight.

For detailed analysis of these specific stock movements and Iridian Asset Management's overall investment strategy, investors and analysts can refer to the full Form 13F filing available on the SEC website or through services like InsiderSet. The fund's actions, particularly the large increases in specific positions, warrant further scrutiny for potential investment implications.